Chinese Journal of New Drugs 2007 Issue 19 hui yi tong zhi

hui yi tong zhi

..............page:1626

xin yao zi xun

..............page:1544,1556,1618

zhu she yong dna zhong zu sheng chang yin zi
lei bing tuan ; bai qiu jiang ; wu ye hong

..............page:1627-1628

New marketed anti-viral drugs in 2005-2006
WANG Jun;LIU Xin-yong

..............page:1624-1626

Rosiglitazone attenuates renal injury in diabetic rats via inhibiting over-expression of matrix metalloproteinase-9 in the kidney
YAO Xin-ming;YE Shan-dong;QIAN Yan;CHEN Yan;FAN Ai-hong;LI Xiu-cai;YANG Guang-wei

..............page:1577-1581

Studies on the pharmacokinetic profiles of baicalin and wogonoside in diabetic rats after oral administration of extract of Scutellariae Radix
DENG Yuan-xiong;YU Sen;CHEN Tian-yan;LIU Li;WANG Dian-lei;XIE Lin;LIU Xiao-dong

..............page:1573-1577

Therapeutic effects of two ethanol extracts of compound Rehmannia decoction on diabetic retinopathy and nephropathy in STZ-induced diabetes rats
ZHANG Yuan;NA Tao;DAI De-zai;LIU Hao-ran;DAI Yin

..............page:1569-1573

Progress of new liposomes modified with strengthened material
KONG Wei-jun;GUO Wei-ying

..............page:1565-1568

Recent progress of hyperinsulinemic-euglycemic clamp technique
DONG Li-hou;SONG Hai-feng

..............page:1561-1564

Current advance in screening of aldose reductase inhibitors
TANG Zhang-yong;TANG Can

..............page:1557-1560

Application of endothelin receptor antagonists in diabetic complication
GAO Feng;LIANG Yuan-jun;DONG Jun-jun;LIU Ke-liang

..............page:1552-1556

Conception of supervision system of Chinese pharmaceutical market
GAO Xiang;CHEN Rong-qiu

..............page:1547-1552

Problems in preparation of toxic herbs in the process of research and development of new Traditional Chinese Medicine
WANG Ting;HAN Ling;JIN Fang;CHENG Long

..............page:1545-1546

Development trends of the post-marketing drug safety surveillance systems in EU and US
ZHANG Huan-zhi;SHI Lu-wen

..............page:1541-1544

Bioequivalence of dextromethorphan hydrobromide after administration of orally disintegrating tablets(ODT)
SONG Dong-mei;FENG Wei;WANG Lin-lin;LIU Hui;LIU Xiao-xi;YAN Dong

..............page:1619-1623

ka ma xi ping zhi yan zhong yao zhen yi li
ma jin qiu ; wei ying

..............page:1618

Pharmacokinetics and bioequivalence of gatifloxacin soft capsule in healthy volunteers
ZHU Ling;ZHANG Hong-ling;CHEN Cheng-qun;HU Yu-rong;ZHOU Tian-yang;QIN Yu-hua;ZHANG Zhen-zhong

..............page:1614-1617

er jia shuang zuo he da ying -35 zhi liao gao xiong ji su xing duo nang luan chao zong he zheng de lin chuang guan cha
li xue peng ; xiao yu feng ; guo feng

..............page:1612-1613

Relationship between dose of irbesartan and renal protection in patients with type 2 diabetes
ZHOU Jun-ge;LI Jing;GUO Jie

..............page:1610-1612

Preparation of vitamin C vaginal sustained-release tablets
LI Yin-bo;LI Jian-he;PENG Liu-bao

..............page:1605-1609

Preparation and in vitro release of carvedilol stomach buoyant tablets
TA Ren-zhi;REN Jun-gang;JIN Li-na;WU Gao-lei

..............page:1602-1605

The synthesis of pancuronium bromide
WANG Yu-cheng;CHEN Yu-fang;GU Fei;GU Shun-lin

..............page:1599-1602

Design and synthesis of mutual prodrugs for relieving neuropathic pain (Ⅰ)
SHI Wei-guo;LIU He;ZHONG Bo-hua

..............page:1592-1599

Anti-diabetic activity of the extraction from Cansha (Bombyx mori L. )as a novel alpha-glucosidase inhibitor
LIU Quan;QIAO Feng-xia;YE Fei;XIE Ming-zhi;SHEN Zhu-fang

..............page:1589-1592

The effect of musclin for PI3K/AKT (PKB) pathway in the way of insulin-induced differented rat myocytes glucose uptakeing
LIU Ying;ZONG Zhi-hong;LIU Guo-liang

..............page:1585-1588

Glycometabolism of sulfonylurea compound G004 in vitro and in vivo
LIU Xiao-qian;WU Guan-zhong;GAO Cong;ZHANG Wen-ping;MA Ying;SU Xin

..............page:1581-1584